A Study to Assess the Effectiveness and Safety of Irinotecan Liposome Injection, 5-fluorouracil/Leucovorin Plus Oxaliplatin in Patients Not Previously Treated for Metastatic Pancreatic Cancer, Compared to Nab-paclitaxel+Gemcitabine Treatment

NCT04083235 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

770

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Adenocarcinoma of the Pancreas

Interventions

DRUG: Irinotecan Liposomal Injection
DRUG: Oxaliplatin
DRUG: 5Fluorouracil
DRUG: Leucovorin
DRUG: Nab-paclitaxel
DRUG: Gemcitabine

Sponsor

Ipsen